Role of nucleoside diphosphate kinase in the activation of anti-HIV nucleoside analogs.
Nucleoside analogs are currently used in antiretrovirus therapies. The best known example is AZT one of the first drug to be used for the treatment of AIDS. However, only the triphosphate derivatives of these compounds act as substrates of the viral reverse transcriptase. Since they do not enter cells, nucleoside analogs are administered and phosphorylated by cellular kinases. The last step in this phosphorylation pathway is catalyzed by nucleoside diphosphate (NDP) kinase. The incorporation of the nucleoside triphosphates into nascent viral DNA chain results in termination of the elongation process. We have performed kinetics studies of the phosphorylation reaction by NDP kinase of dideoxynucleoside diphosphates such as 2',3'-dideoxy-3'-azidothymidine diphosphate (AZT-DP) and 2',3'-dideoxy-2',3'-didehydrothymidine diphosphate (d4T-DP). We show that the catalytic efficiency is strongly decreased and, therefore, that the reaction step catalyzed by NDP kinase constitutes a bottleneck in the processing pathway of anti-HIV compounds. In addition, the affinity of the analogs in the absence of catalysis was determined using a catalytically inactive NDP kinase mutant, showing a reduction of affinity by a factor of 2 to 30, depending on the analog. The structure of NDP kinase provides a structural explanation for these results. Indeed, all nucleoside analogs acting as chain terminators must lack a 3'-OH in the nucleotide deoxyribose. Unfortunately, this same substitution is detrimental for their capacity to be phosphorylated by NDP kinase. This defines the framework for the design of new nucleoside analogs with increased efficiency in antiretroviral therapies.
Schneider
B
B
Institut Pasteur, Unité de Régulation Enzymatique des Activités Cellulaires, CNRS URA 1773, Paris, France.
Sarfati
R
R
Deville-Bonne
D
D
Véron
M
M
D019380:Anti-HIV Agents / Q000378:metabolism*; D006801:Humans; D009701:Nucleoside-Diphosphate Kinase / Q000378:metabolism* / Q000502:physiology; D009705:Nucleosides / Q000378:metabolism*; D010766:Phosphorylation; D013379:Substrate Specificity
D019380:Anti-HIV Agents; D009705:Nucleosides; D009701:Nucleoside-Diphosphate Kinase